The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily

被引:598
作者
Sherwood, NM [1 ]
Krueckl, SL [1 ]
McRory, JE [1 ]
机构
[1] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada
关键词
D O I
10.1210/er.21.6.619
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily includes nine hormones in humans that are related by structure, distribution (especially the brain and gut), function (often by activation of cAMP), and receptors (a subset of seven-transmembrane receptors). The nine hormones include glucagon, glucagon-like peptide-1 (GLP-1), GLP-2, glucose-dependent insulinotropic polypeptide (GIP), GH-releasing hormone (GRF), peptide histidine-methionine (PHM), PACAP, secretin, and vasoactive: intestinal polypeptide (VIP). The origin of the ancestral superfamily members is at least as old as the invertebrates; the most ancient and tightly conserved members are PACAP and glucagon. Evidence to date suggests the superfamily began with a gene or exon duplication and then continued to diverge with some gene duplications in vertebrates. The function of PACAP is considered in detail because it is newly (1989) discovered; it is tightly conserved (96% over 700 million years); and it is probably the ancestral molecule. The diverse functions of PACAP include regulation of proliferation, differentiation, and apoptosis in some cell populations. In addition, PACAP regulates metabolism and the cardiovascular, endocrine, and immune systems, although the physiological event(s) that coordinates PACAP responses remains to be identified.
引用
收藏
页码:619 / 670
页数:52
相关论文
共 647 条
  • [71] Carlsson PO, 1996, REGUL PEPTIDES, V63, P123
  • [72] CARROLL RL, 1997, PATTERNS PROCESSES V, P1
  • [73] PROPERTIES AND DISTRIBUTION OF RECEPTORS FOR PITUITARY ADENYLATE-CYCLASE ACTIVATING PEPTIDE (PACAP) IN RAT-BRAIN AND SPINAL-CORD
    CAUVIN, A
    ROBBERECHT, P
    DENEEF, P
    GOURLET, P
    VANDERMEERS, A
    VANDERMEERSPIRET, MC
    CHRISTOPHE, J
    [J]. REGULATORY PEPTIDES, 1991, 35 (02) : 161 - 173
  • [74] PEPTIDE HISTIDINE ISOLEUCINAMIDE (PHI)-(1-27)-GLY AS A NEW MAJOR FORM OF PHI IN THE RAT SMALL-INTESTINE
    CAUVIN, A
    VANDERMEERS, A
    VANDERMEERSPIRET, MC
    RATHE, J
    ROBBERECHT, P
    CHRISTOPHE, J
    [J]. ENDOCRINOLOGY, 1989, 125 (03) : 1296 - 1302
  • [75] VARIABLE DISTRIBUTION OF 3 MOLECULAR-FORMS OF PEPTIDE HISTIDINE ISOLEUCINAMIDE IN RAT-TISSUES - IDENTIFICATION OF THE LARGE MOLECULAR-FORM AS PEPTIDE HISTIDINE VALINE-(1-42)
    CAUVIN, A
    VANDERMEERS, A
    VANDERMEERSPIRET, MC
    ROBBERECHT, P
    CHRISTOPHE, J
    [J]. ENDOCRINOLOGY, 1989, 125 (05) : 2645 - 2655
  • [76] Cavallaro S, 1996, MOL PHARMACOL, V50, P60
  • [77] Isolation and structural characterization of proglucagon-derived peptides, pancreatic polypeptide, and somatostatin from the urodele Amphiuma tridactylum
    Cavanaugh, ES
    Nielsen, PF
    Conlon, JM
    [J]. GENERAL AND COMPARATIVE ENDOCRINOLOGY, 1996, 101 (01) : 12 - 20
  • [78] Identification and characterization of a receptor from goldfish specific for a teleost growth hormone-releasing hormone-like peptide
    Chan, KW
    Yu, KL
    Rivier, J
    Chow, BKC
    [J]. NEUROENDOCRINOLOGY, 1998, 68 (01) : 44 - 56
  • [79] Cyclic AMP and sympathetic neuronal programmed cell death
    Chang, JY
    Korolev, VV
    [J]. NEUROCHEMISTRY INTERNATIONAL, 1997, 31 (02) : 161 - 167
  • [80] SECRETIN MODULATION OF BEHAVIORAL AND PHYSIOLOGICAL FUNCTIONS IN THE RAT
    CHARLTON, CG
    MILLER, RL
    CRAWLEY, JN
    HANDELMANN, GE
    ODONOHUE, TL
    [J]. PEPTIDES, 1983, 4 (05) : 739 - 742